SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-150861
Filing Date
2022-05-16
Accepted
2022-05-16 07:14:32
Documents
13
Period of Report
2022-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d297716d8k.htm   iXBRL 8-K 25583
2 EX-99.1 d297716dex991.htm EX-99.1 9185
  Complete submission text file 0001193125-22-150861.txt   164586

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA scph-20220516.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20220516_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20220516_pre.xml EX-101.PRE 11728
7 EXTRACTED XBRL INSTANCE DOCUMENT d297716d8k_htm.xml XML 3461
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 22925414
SIC: 2834 Pharmaceutical Preparations